Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia
about
Determination of Interleukin-6 and Tumor Necrosis Factor-alpha concentrations in Iranian-Khorasanian patients with preeclampsia.Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentAcute Atherosis of the Uterine Spiral Arteries: Clinicopathologic ImplicationsVitamin D and Inflammatory Cytokines in Healthy and Preeclamptic PregnanciesCytokines as key players in the pathophysiology of preeclampsiaNew approaches for managing preeclampsia: clues from clinical and basic researchProtective effect of nuclear factor E2-related factor 2 on inflammatory cytokine response to brominated diphenyl ether-47 in the HTR-8/SVneo human first trimester extravillous trophoblast cell lineSoluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia.Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsiaVascular and cellular calcium in normal and hypertensive pregnancyMonocytes and macrophages in pregnancy and pre-eclampsiaMaternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia.Maternally sequestered therapeutic polypeptides - a new approach for the management of preeclampsiaInterleukin-10 inhibits the in vivo and in vitro adverse effects of TNF-alpha on the endothelium of murine aorta.Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium.Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus.Tetrabromobisphenol A activates inflammatory pathways in human first trimester extravillous trophoblasts in vitro.Digibind attenuates cytokine TNFalpha-induced endothelial inflammatory response: potential benefit role of digibind in preeclampsia.Elevated maternal soluble Gp130 and IL-6 levels and reduced Gp130 and SOCS-3 expressions in women complicated with preeclampsia.Early onset pre-eclampsia is associated with altered DNA methylation of cortisol-signalling and steroidogenic genes in the placentaMaternal Schistosomiasis japonica is associated with maternal, placental, and fetal inflammation.Elevated maternal IL-16 levels, enhanced IL-16 expressions in endothelium and leukocytes, and increased IL-16 production by placental trophoblasts in women with preeclampsia.Involvement of Galectin-9/TIM-3 pathway in the systemic inflammatory response in early-onset preeclampsiaEffect of tumour necrosis factor-alpha and interleukin 1beta on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitro.Biological functions of thyroid hormone in placentaMaternal serum adiponectin multimers in preeclampsia.The frequency of acute atherosis in normal pregnancy and preterm labor, preeclampsia, small-for-gestational age, fetal death and midtrimester spontaneous abortionPreeclampsia: multiple approaches for a multifactorial diseaseAutoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia.Uric acid as a pathogenic factor in preeclampsia.Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation and sequence-based methodsPre-eclampsia: is it all in the placenta?Heme oxygenase induction attenuates TNF-α-induced hypertension in pregnant rodents.Nicotine inhibits cytokine production by placenta cells via NFkappaB: potential role in pregnancy-induced hypertension.Oxidative damage, inflammation, and Toll-like receptor 4 pathway are increased in preeclamptic patients: a case-control study.Endothelin: key mediator of hypertension in preeclampsia.Linking placental ischemia and hypertension in preeclampsia: role of endothelin 1.Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia.Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products.Analysis of polymorphisms in interleukin-10, interleukin-6, and interleukin-1 receptor antagonist in Mexican-Mestizo women with pre-eclampsia.
P2860
Q24814161-3BD2D3B1-4CDB-49C4-AF7B-F93D875CC254Q26766128-556F2A17-ABF7-45BD-BDC9-26BF5E18089CQ26777023-06490CD2-CA80-49FE-940E-F31A20EA4D91Q26801481-27A38AA5-0F11-4F1F-8604-CD6D4ADB69F9Q26830707-1A8CE285-3272-47A3-838F-440966C39BC4Q27010670-4AFCC43B-1940-4DCB-854A-1BBB62CE1CA1Q28391645-9E3B688A-DFF6-4876-AEED-E8BBBC99E4D0Q33650241-1CFEBBF2-31AB-4BA6-8A44-9C6505166DFAQ33748650-3018C896-018E-44E5-BD02-2B5C4816B3C4Q33781354-33E28272-3FA9-46F1-82D9-33E3E0500DD4Q33820908-0C72B763-42FC-418F-AE7A-8D05673C7017Q33821579-8C938F09-4DDF-43B8-A663-23CEF307363AQ34140082-9C09DD92-D360-4EAD-81E3-E229E6402106Q34212252-833050F7-1CA3-44C9-B805-0C6FAB6120F4Q34280666-C2F90F76-DC8A-4B2E-BA64-2830DAE546EEQ34424622-743F6075-70F1-4781-8107-B591DBB9220BQ34662474-AC1692BA-F774-40ED-AF5F-D6E61BFDAC0CQ34707051-3BC3A009-DBE8-4A30-9926-0037C88F2882Q34707068-B7DE0EAC-3B00-4709-B1D0-68E22A6D489EQ34717931-DC39B82E-5995-45A5-9F91-854018F07734Q34739827-A9118FDD-FAF9-495C-A9DA-87D6F88E0C81Q34768918-E6A402FF-CC01-4182-99E7-3A0B62E27886Q34927088-2602EEEF-9018-415D-BF67-889B5103827FQ35045161-8A48827E-B552-48E5-85CC-2A68095A5830Q35139213-261ACA8E-E37E-4A89-85A3-22BFF1835EB6Q35194054-AE92403E-BA78-4A71-B076-8AD376FC8881Q35593888-E73F5E3D-E599-4B0A-9575-4C693A3C4AF4Q35665007-1AB2C395-F3AA-4A13-A2A9-5B0F6B3AB520Q35715914-97E8F170-5261-499D-85FF-5555CEB62608Q35868968-80CBC54E-52C1-4016-B8E7-00E0C47D377BQ35886564-79CFBDDD-02A1-46BF-A0F9-64C1E7F04C32Q35911954-7463E0C2-C6DA-4770-87C8-90BB69F8F268Q35960186-EA942FCA-DF2D-4CBC-B778-4D6421197FACQ35995193-BA46EF79-120E-4C29-90BA-365748EC7171Q36072850-BAA25C50-26BC-4522-B6A3-889D51C22A52Q36073225-C33AAB3D-9EBC-45CB-9515-18E7BD011ADCQ36106483-1E9B328A-0E5D-4C73-BBBE-923C3C94EE31Q36185268-C2A7DAEA-705E-41F7-B25A-E75AF7114D0EQ36351625-14A33450-756A-4A87-AE82-36FB28E96D13Q36353178-A981CFD9-BAE2-430B-9099-3888511BF953
P2860
Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia
description
wetenschappelijk artikel (gepubliceerd in 1995-01)
@nl
наукова стаття, опублікована в січні 1995
@uk
name
Interleukin-6, tumour necrosis ...... rs in women with pre-eclampsia
@en
Interleukin-6, tumour necrosis ...... rs in women with pre-eclampsia
@nl
type
label
Interleukin-6, tumour necrosis ...... rs in women with pre-eclampsia
@en
Interleukin-6, tumour necrosis ...... rs in women with pre-eclampsia
@nl
prefLabel
Interleukin-6, tumour necrosis ...... rs in women with pre-eclampsia
@en
Interleukin-6, tumour necrosis ...... rs in women with pre-eclampsia
@nl
P2093
P921
P1476
Interleukin-6, tumour necrosis ...... rs in women with pre-eclampsia
@en
P2093
C W Redman
D Kwiatkowski
P M Starkey
R Austgulen
P356
10.1111/J.1471-0528.1995.TB10859.X
P407
P577
1995-01-01T00:00:00Z